INTS insider transaction filings

INTENSITY THERAPEUTICS, INC. — 22 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-20. Screen INTS transaction legs live →

FiledFormInsiderReported transactionsSource
2026-07-204Donovan Daniel — DirectorGrant/award (A): 5,500 (derivative) @ $0EDGAR
2026-07-204Wesolowski John M — Principal Accounting OfficerGrant/award (A): 11,000 (derivative) @ $0EDGAR
2026-07-204Leahy Emer — DirectorGrant/award (A): 5,500 (derivative) @ $0EDGAR
2026-07-204Talamo Joseph — Chief Financial OfficerGrant/award (A): 34,000 (derivative) @ $0EDGAR
2026-07-204GOLDBERG MARK A — DirectorGrant/award (A): 5,500 (derivative) @ $0EDGAR
2026-07-204BENDER LEWIS H — President and CEO, DirectorGrant/award (A): 78,000 (derivative) @ $0EDGAR
2026-07-204DUBIN THOMAS I H — DirectorGrant/award (A): 5,500 (derivative) @ $0EDGAR
2026-07-014Wesolowski John M — Principal Accounting OfficerGrant/award (A): 3,688 @ $3.48EDGAR
2026-07-014Talamo Joseph — Chief Financial OfficerGrant/award (A): 1,093 @ $3.48EDGAR
2026-03-304BENDER LEWIS H — President and CEO, DirectorGrant/award (A): 37,749 @ $6.11EDGAR
2026-01-054Wesolowski John M — Principal Accounting OfficerGrant/award (A): 8,918 @ $0.26EDGAR
2026-01-054Talamo Joseph — Chief Financial OfficerGrant/award (A): 14,482 @ $0.26EDGAR
2025-07-024Wesolowski John M — Principal Accounting OfficerGrant/award (A): 69,745 @ $0.26EDGAR
2025-07-024Talamo Joseph — Chief Financial OfficerGrant/award (A): 14,179 @ $0.26EDGAR
2025-05-064Wesolowski John M — Principal Accounting OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-05-064Donovan Daniel — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-064Leahy Emer — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-064Wesolowski John M — Principal Accounting OfficerGrant/award (A): 100,000 (derivative) @ $0EDGAR
2025-05-064Talamo Joseph — Chief Financial OfficerGrant/award (A): 300,000 (derivative) @ $0EDGAR
2025-05-064GOLDBERG MARK A — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-064BENDER LEWIS H — President and CEO, Director, 10% ownerGrant/award (A): 700,000 (derivative) @ $0EDGAR
2025-05-064DUBIN THOMAS I H — DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR

Recent 8-K events — INTENSITY THERAPEUTICS, INC.

FiledFormItems reportedSource
2026-08-118-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-168-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-05-078-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-278-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-238-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-068-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-03-058-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-02-138-K3.03 — Material Modification to Rights of Security Holders
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-058-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-048-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=INTS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →